Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Asthma, Date of authorisation: 08/01/2018, Revision: 13, Status: Authorised

Public health threats

Human medicines European public assessment report (EPAR): Degarelix Accord, degarelix, Prostatic Neoplasms, Date of authorisation: 29/09/2023, Status: Authorised

Legal framework: Pharmacovigilance

Paediatric medicines: Overview

Medical devices

Fees payable to the European Medicines Agency

Advanced therapy medicinal products: Overview

Human medicines European public assessment report (EPAR): Rizmoic, naldemedine, Constipation, Date of authorisation: 18/02/2019, Revision: 10, Status: Authorised

Withdrawn application: RoActemra, tocilizumab, Date of withdrawal: 13/09/2023, Post-authorisation